KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Up 34.8% in February

KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) saw a large growth in short interest in February. As of February 28th, there was short interest totalling 506,600 shares, a growth of 34.8% from the February 13th total of 375,900 shares. Approximately 1.2% of the company's stock are short sold. Based on an average daily volume of 174,800 shares, the days-to-cover ratio is currently 2.9 days.

KORU Medical Systems Stock Up 0.7 %

KORU Medical Systems stock traded up $0.02 during trading on Thursday, hitting $2.94. 75,600 shares of the company were exchanged, compared to its average volume of 136,377. The company has a market capitalization of $135.11 million, a P/E ratio of -11.72 and a beta of 0.74. The business's 50 day moving average is $3.88 and its 200 day moving average is $3.41. KORU Medical Systems has a 52 week low of $2.05 and a 52 week high of $5.05. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01.

Institutional Trading of KORU Medical Systems

Several institutional investors have recently made changes to their positions in KRMD. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock worth $168,000 after purchasing an additional 26,860 shares during the last quarter. XTX Topco Ltd bought a new position in shares of KORU Medical Systems during the 3rd quarter worth approximately $34,000. Geode Capital Management LLC lifted its position in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after buying an additional 28,323 shares in the last quarter. Empire Financial Management Company LLC purchased a new position in shares of KORU Medical Systems in the 3rd quarter worth approximately $259,000. Finally, Calamos Advisors LLC bought a new position in shares of KORU Medical Systems in the fourth quarter valued at approximately $250,000. Institutional investors own 58.60% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of brokerages recently commented on KRMD. Lake Street Capital boosted their target price on KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a research report on Tuesday, January 14th. Piper Sandler reaffirmed a "neutral" rating and set a $4.50 target price on shares of KORU Medical Systems in a research report on Friday, February 14th. B. Riley raised shares of KORU Medical Systems to a "strong-buy" rating in a research report on Thursday, March 13th. Finally, Craig Hallum boosted their price target on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, January 17th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, KORU Medical Systems presently has an average rating of "Buy" and an average target price of $4.70.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.